Skip to Content

Synagis Prices, Coupons and Patient Assistance Programs

Synagis (palivizumab) is a member of the immune globulins drug class and is commonly used for Respiratory Syncytial Virus.

Synagis Prices

This Synagis price guide is based on using the discount card which is accepted at most U.S. pharmacies. The cost for Synagis intramuscular solution (100 mg/mL) is around $1,652 for a supply of 0.5 milliliters, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

Intramuscular Solution

100 mg/mL Synagis intramuscular solution
from $1,651.94 for 0.5 milliliters
Quantity Per unit Price
0.5 milliliters $3,303.88 $1,651.94
1 milliliter(s) $3,110.89 $3,110.89

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee. Printable Discount Card

Print Now

The free Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.

Synagis Coupons and Rebates

Synagis offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.

Patient Assistance Programs for Synagis

Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.

Provider: Synagis CONNECT

Elligibility requirements:

  1. Must be uninsured or underinsured
  2. At or below 500% of FPL
  3. FDA-approved diagnosis
  4. Must be a US citizen or permanent resident and treated by a US licensed healthcare provider
  5. Co-payment assistance, reimbursement support, and patient assistance programs are available for eligible patients.

Applicable drugs:

  • Synagis (palivizumab) Injection